Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cardlytics Q2 2024 Adj. EPS $(0.15) Misses $(0.13) Estimate, Sales $69.636M Miss $75.367M Estimate

Author: Benzinga Newsdesk | August 07, 2024 05:02pm
Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. The company reported quarterly sales of $69.636 million which missed the analyst consensus estimate of $75.367 million by 7.60 percent. This is a 9.21 percent decrease over sales of $76.701 million the same period last year.

Posted In: CDLX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist